Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in CLE and SLE with Active Skin Lesions
NCT01551069Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in cutaneous lupus erythematosus (CLE), systemic lupus erythematosus (SLE), sponsored by Sanofi. Started Mar 2012; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
cutaneous lupus erythematosus (CLE)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01551069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01551069.